Park medi world limited IPO Overview
Park medi world limited IPO is a Mainboard public issue offered through a Book Building issue with a total issue size of ₹920.00 Cr. The IPO price band is set at ₹154 to ₹162 per share, and retail investors can apply with a minimum investment of ₹14,904 as per IPO guidelines.
The Park medi world limited IPO opens on 10 Dec 2025 and closes on 12 Dec 2025. The IPO allotment is expected to be finalized on 15 Dec 2025, and the equity shares are proposed to be listed on BSE,NSE on 17 Dec 2025.
Investors can refer to the Park medi world limited IPO RHP-DRHP for detailed information. The issue is managed by Nuvama Wealth Management Ltd as the book running lead manager, while Kfin Technologies Limited is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About park medi world limited
The company operates 14 multi-super speciality hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network includes facilities in Haryana, Delhi, Punjab, and Rajasthan.
Park Hospital offers more than 30 super speciality and speciality services, such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.
As of Sep 30, 2025, the hospitals are equipped with 870 bedded intensive care unit (ICU) beds, 67 operating theatres (OTs), and an oxygen generation plant at each location to support critical care.
It has hospitals across several states including Haryana (Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad), Delhi, Punjab (Patiala, Mohali), and Rajasthan (Jaipur, Behror).
As of September 30, 2025, Park Medi World Limited had a workforce of 1,014 doctorsa and 2,142 nurses